Frontiers Lu-177-PSMA dosimetry for kidneys and tumors based on

Frontiers Lu-177-PSMA dosimetry for kidneys and tumors based on

Frontiers Quantitative imaging for 177Lu-PSMA treatment response

Lu-177 PSMA therapy in Germany

Tumor and organ dosimetry from sequential quantitative SPECT/CT

Intra-therapeutic dosimetry of [177Lu]Lu-PSMA-617 in low-volume

Nuclear Medicine Applications in Prostate Cancer

SNMMI 2023: Tumour-to-Kidney Ratio on Pre-Therapeutic PSMA-PET-CT

Radiation Dosimetry in 177Lu-PSMA-617 Therapy - ScienceDirect

PDF) Towards Single Time Point Image-Based Dosimetry of 177 Lu

Investigation of image-based lesion and kidney dosimetry protocols